EUVIMEDEUVIMED entdecken
Crossref

Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants

Marina P Menegolla, Rita C Silveira, Antônio R H Görgen, Fernanda E Gandolfi, Renato S Procianoy iD

Pediatric Pulmonology · 2024

DOI: 10.1002/ppul.27182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Marina P Menegolla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Universidade Federal do Rio Grande do Sul, Newborn Section, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Anti-Bacterial Agents, Infant, Very Low Birth Weight, Infant, Premature. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bronchopulmonary dysplasia (BPD) remains a significant challenge in neonatal care. Prenatal inflammation and neonatal sepsis contribute to the multifactorial nature of BPD. A potential association between empirical antibiotic therapy and BPD risk has been proposed due to microbiota dysbiosis in very low birth weight premature infants.

Methods

A single centered retrospective cohort study of preterm infants (24–32 weeks gestation) from 2014 to 2021. The study compared groups that received empirical antibiotics in the first days of life and those that did not receive any antibiotic in the first days of life. The primary outcomes studied were BPD, death, and the combined outcome of BPD/death. Statistical analysis employed t ‐tests, Mann‐Whitney U, Chi‐square, and logistic regression.

Results

Of 454 preterm infants, 61.5% received antibiotics. This group had lower gestational age, birth weight, and Apgar scores. Antibiotic use was associated with higher incidence of BPD (35.5% vs. 10.3%), death (21.5% vs. 8.6%), and combined outcomes (54.5% vs. 18.3%). In multivariate analysis, antibiotic use independently associated with BPD (OR 2.58, p < 0.001) and combined outcome BPD/death (OR 2.06, p < 0.02). Antenatal corticosteroids provided protection against BPD, but not mortality.

Conclusion

This study suggests an association between early empirical antibiotic use and BPD in preterm infants, emphasizing the need for judicious antibiotic practices in neonatal care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchopulmonary DysplasiaAnti-Bacterial AgentsInfant, Very Low Birth WeightInfant, PrematureHumansInfant, NewbornRetrospective StudiesFemaleMaleGestational AgeIncidenceInfant, Extremely Premature

Stichwörter der Autor:innen

antimicrobial stewardshipbronchopulmonary dysplasiamortalityneonatal sepsisvery low birth weight newborn

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Universidade Federal do Rio Grande do Sul, Newborn Section, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

ORCID-Profile: Renato S Procianoy

Förderung

  • None

Zitieren

APA

Menegolla, M. P., Silveira, R. C., Görgen, A. R. H., Gandolfi, F. E., & Procianoy, R. S. (2024). Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27182

Vancouver

Menegolla MP, Silveira RC, Görgen ARH, Gandolfi FE, Procianoy RS. Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27182

BibTeX
@article{Menegolla2024,
  author = {Menegolla, Marina P and Silveira, Rita C and Görgen, Antônio R H and Gandolfi, Fernanda E and Procianoy, Renato S},
  title = {Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants},
  journal = {Pediatric Pulmonology},
  year = {2024},
  doi = {10.1002/ppul.27182}
}
Kostenlos starten →